Atlas Trials

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Clinical trial NCT04164069 · COMPLETED

Trial details

NCT number
NCT04164069
Sponsor
Anne Noonan
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8Stage IVC Colorectal Cancer AJCC v8Stage II Colon CancerStage II Rectal CancerStage III Colon CancerStage III Rectal CancerEsophageal CancerPancreatic Cancer
Start date
2020-09-02
Primary completion
2023-06-22
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.